Manufacturer identification
Identify suitable pharmaceutical manufacturers against the product, dosage form, capacity, documentation and destination-market brief.
International pharmaceutical trade
KOIT coordinates pharmaceutical exports from suitable manufacturing partners to international buyers and markets, aligning product sourcing, manufacturer capabilities, buyer requirements, export documentation, commercial terms and logistics follow-up.
Merchant export explained
In pharmaceutical merchant export, a merchant exporter sources products from a suitable manufacturer and manages the commercial export transaction with an overseas buyer. The manufacturer produces and releases the goods, while the merchant exporter coordinates the supplier, buyer, documents and shipment flow.
This differs from a manufacturer export, where the manufacturer sells directly to the overseas buyer. It also differs from contract manufacturing and neutral-code manufacturing, which concern how a product is manufactured to agreed buyer requirements.
Merchant export should not be confused with Merchant Trade Transactions (MTT). Merchant export typically involves an export from India; MTT involves goods moving between overseas jurisdictions under a distinct commercial structure.
KOIT’s capabilities
KOIT acts as the international pharmaceutical business-development and merchant-export partner, coordinating the organizations responsible for manufacturing, buying, documentation, regulatory work and logistics.
Identify suitable pharmaceutical manufacturers against the product, dosage form, capacity, documentation and destination-market brief.
Align strength, presentation, pack configuration, quantity, quality expectations and other buyer-specific requirements.
Coordinate quotations, quantities, timelines, payment terms and responsibilities between the manufacturer and international buyer.
Support the exchange and alignment of commercial, product, quality and shipment documents required for the transaction.
Coordinate available pack formats, artwork inputs and labelling requirements subject to manufacturer capability and applicable rules.
Coordinate freight inputs, dispatch readiness, document flow and shipment milestones with the responsible service providers and parties.
Manufacturing origin
KOIT can connect international buyers with suitable Indian pharmaceutical manufacturers for finished pharmaceutical products, generic medicines and relevant therapeutic product categories. Selection considers product capability, documentation, quantity, market requirements and commercial fit.
Available GMP documentation is reviewed according to the proposed manufacturer and product. Certification varies by site and market: not every manufacturer holds WHO-GMP or EU-GMP credentials, and such credentials do not replace destination-country product approval.
Explore pharmaceutical sourcing from IndiaDocuments and compliance
The required document set changes with the product, manufacturing site, mode of transport, export route, destination and buyer responsibilities.
KOIT coordinates document inputs and consistency among the manufacturer, buyer, logistics providers and relevant regulatory parties. The responsible exporter, importer and professional advisers must confirm what applies to each transaction.
KOIT does not grant registrations or approvals and does not provide universal legal, customs, banking or tax advice. For destination-market support, see our product registration and regulatory coordination capability.
Destination markets
KOIT evaluates opportunities across Latin America, Southeast Asia, Africa and other international markets through a market-specific commercial and documentary lens.
Coordinate supply opportunities with established importers, distributors, pharmaceutical companies and institutional partners according to each market’s product and import requirements.
Match buyer requirements with appropriate manufacturing capabilities while accounting for local registration, importer, packaging and documentation responsibilities.
Support commercially viable private, distribution-led and institutional requirements where the product, manufacturer and route meet the destination market’s needs.
Assess each opportunity individually based on product fit, counterparty readiness, applicable documentation and a compliant route to market.
Choosing the right structure
Both can support international pharmaceutical supply, but their physical movement, commercial flow and documentation are different.
Products are sourced from an Indian manufacturer and exported from India to an overseas buyer. The structure involves Indian export documentation, banking and regulatory considerations alongside destination-country requirements.
Goods move from one overseas jurisdiction to another while the coordinating commercial party may be based elsewhere. The transaction requires its own cross-border commercial, documentary, banking and regulatory assessment.
Explore Merchant Trade TransactionsWho we work with
Requirements outside a routine commercial import route may also be assessed through KOIT’s Special Purpose Import coordination capability.
Process
Define the product, specifications, quantity, target market, buyer profile and expected supply timeline.
Identify suitable manufacturing partners and review initial capability and document availability.
Align specifications, pricing, quantities, payment terms, packaging, delivery terms and responsibilities.
Coordinate export, product and quality documents with the manufacturer, buyer and responsible regulatory parties.
Track production readiness, document exchange, dispatch and agreed shipment milestones.
FAQ
Pharmaceutical merchant export is a commercial arrangement in which an export partner sources products from a suitable manufacturer and supplies them to an international buyer. The merchant exporter coordinates the commercial transaction and export flow, while manufacturing remains with the qualified manufacturer and destination-market responsibilities remain with the appropriate buyer, importer and regulatory parties.
Yes. KOIT can identify and coordinate with suitable Indian manufacturers for finished pharmaceutical products and generic medicines. The match depends on the product, dosage form, documentation, quantity, commercial terms and destination-market requirements.
Requirements commonly include a commercial invoice, packing list, shipping bill, transport document and Certificate of Origin, together with relevant product, quality and regulatory documents. The exact set depends on the product, export route, buyer, destination country and current requirements.
Yes. KOIT coordinates product specifications, quantities, packaging, documentation, commercial discussions and shipment inputs between suitable manufacturers and international buyers. Final acceptance and regulated responsibilities remain with the relevant parties.
Merchant export generally involves products exported from India to an overseas buyer through an Indian merchant exporter. In a Merchant Trade Transaction, goods move between two overseas jurisdictions while the coordinating commercial party may be based in another country. The structures have different commercial, documentary, banking and regulatory considerations.
It may. Product registration, import authorization, establishment licensing and other requirements depend on the product, intended use and destination country. Merchant export does not bypass those obligations, and KOIT does not guarantee registration or approval.
KOIT can assess institutional and procurement-led requirements, identify suitable supply options and coordinate product, manufacturer, commercial and documentation inputs. Eligibility, procurement participation, import authorization and awards remain subject to the applicable process and responsible organizations.
Discuss your requirement
Share the product, quantity, target market, buyer requirements and expected timeline. KOIT will assess suitable sourcing and merchant-export coordination options.